
USFDA14 Nov 2026, 05:06 pm
Dr Reddy's USFDA Inspection Closed as Voluntary Action Indicated
AI Summary
Dr Reddy's Laboratories Ltd has announced that the United States Food & Drug Administration (USFDA) has concluded its inspection of the company's formulations manufacturing facility (FTO-3) in Bachupally, Hyderabad. The inspection, initially disclosed on August 14, 2026, has been classified as 'Voluntary Action Indicated (VAI)'. The USFDA has officially closed the inspection under 21 CFR 20.64(d)(3), indicating a satisfactory outcome with no major compliance issues requiring immediate mandatory action.
Key Highlights
- USFDA inspection at Bachupally facility concluded.
- Inspection outcome classified as Voluntary Action Indicated (VAI).
- USFDA officially closed the inspection.
- No major compliance issues identified by the regulator.
Price Impact
More from DRREDDY